Search results
FDA approves Moderna’s RSV vaccine mRESVIA
Pharmaceutical Technology via Yahoo Finance· 12 hours agoModerna has secured approval from the US Food and Drug Administration (FDA) for its mRNA-based respiratory syncytial virus (RSV) vaccine mRESVIA...
Experimental mRNA vaccines gain steam with promising cancer trial results
Semafor via Yahoo News· 1 hour agoInsights from TIME, The Washington Post, MIT Technology Review The News Pharmaceutical giants ...
RBC Capital lifts Moderna shares target, highlights RSV vaccine approval By Investing.com
Investing.com· 10 hours agoOn Monday, RBC (TSX:RY) Capital Markets adjusted its outlook on Moderna (NASDAQ:MRNA) shares,...
Moderna-Merck skin cancer vaccine shows survival benefit in long-term follow-up
Reuters via Yahoo News· 9 hours agoDetailed data on Monday from the 157-patient trial showed that after two and a half years, melanoma...
Moderna, Merck say vaccine improved survival in patients with deadly skin cancer
NBC New York· 8 hours agoModerna and Merck said their experimental vaccine in combination with the therapy Keytruda improved survival and showed durable efficacy in a midstage study in patients with ...
Moderna-Merck skin cancer vaccine shows survival benefit in long-term follow-up
Reuters· 9 hours ago, opens new tab said on Monday their cancer vaccine in combination with blockbuster cancer therapy...
An mRNA Melanoma Vaccine Shows Promise
Time Magazine· 9 hours agoModerna says the same mRNA technology that fueled its COVID-19 vaccine is proving effective in fighting melanoma. The company presented the latest...
Moderna, Merck Reveal Three Year Data For Individualized Cancer Therapy In High-Risk Melanoma...
Benzinga· 4 hours agoMonday, Moderna Inc MRNA and Merck & Co Inc MRK announced the first presentation of results from a planned analysis from the Phase 2b KEYNOTE-942/mRNA-4157-P201 study. The ...
FDA approves Moderna’s mRNA RSV vaccine for older adults
CNN via Yahoo News· 3 days agoThe US Food and Drug Administration has approved another vaccine that can help protect older people...
Moderna Wins Second-Ever Approval. But It Could Dominate Pfizer, GSK.
Investor's Business Daily· 3 days agoLike rivals Pfizer (PFE) and GSK (GSK) — which gained their approvals and launched last year — ...
